<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 121 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page120.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=121">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 121 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 121</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=121"><img src="../thumb/121.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>90 / 2020-04                                                                  Autacoids - 6.2
   apart/by const.infus. of 1 mg/hr for up to 24 hrs.OR sngl.dos.of 32 mg   dos.of 8 mg not to be exceed.in mod./sev.hepat.impairm., those hav./  Post-op.N&V: Adults: Prevent: 1 mg (10 µg/kg) by slow.IVI (over
   dil.in 50-100 ml saline or other compat.infus.fluid admin. over not less   poss.devel.QTc prolong.incl.condits./ meds. caus.QT prolong./electrol.  30 secs.) bef.anaesthes.induct. Treatm: Same as prevent. Max.
   than 15 mins.immed.bef. chemother. Effic.may be enhanc.by a sngl.IV   abnorm., hypokalaem./ hypomagnesaem.correct.bef.init. ther., monit.  tot.dos.3 mg IV/day in pts.undergo.anaesthes.for surg. Childr: Not
   dos.of dexamethasone phosph.20 mg 30-45 mins.prior to 1st Alepet   pts.with subac.intest.obstruct., control. sod.diet,few pts.above 80 kg   recomm.as data avail.
   dos. prior to chemother.     or below 40 kg have been stud., hypersens.report.when hypersens.   Contraindications: Childr.und.2 yrs., safety in pregn.& lactat.not
   Childr.over 4 yrs: Limit.exper.but effect.& well-toler.if giv.IV at   to other select. 5-HT3 recept. antagon., limit.data avail.on sev.imp.  est., congenit.long QT-syndr.
      2
   5 mg/m  dos.over 15 mins. immed. bef.chemother.  ren./hepat.funct., safety & effic.in post-op N&V prevent.& treatm. in   Side effects: Somnol., trans.vis.disturbs., infect., UTI, bld.dyscras.,
   Prevent.& treatm.of post-op N&V: Adults: Admin.4 mg undil.IM/  elderly not est., do not admin.in same syr./infus.as other medicat.,   hypersens.reacts.incl.skin rash./ anaphylax., psych./GI disords.,
   IV immed.bef.induct.of anaesthes.or post-op.if naus.&/ vomit.short.   amps.not to be autoclav.  headache, dizzin., seiz., oculogyr.cris., card.disords.incl.ang.pect./
   aft.surg. Admin.in not less than 30 sec., pref.over 2-5 mins.if giv.IV.   Drug interactions: Hypotens./loss of consciousn./ poss.intens.QT   dysrhythm./ chest pain/QT-prolong., faint., flush., hypo-/hypertens.,
   Childr. 2 yrs & over: 0,1 mg/kg up to max. 4 mg by slow IV inj.prior   prolong.with apomorphine, reduc.bld.conc.with phenytoin/ carbamaz-  dyston., dyskines., asthen., fatig., fev., loc.reacts., rise in hepat.
   to, at/aft. induct.of anaesthes.  epine/ rifampicin, reduc.tramadol.eff.  transaminas., poss. reduc.bowel motil.
   Treatm.of est.post-op N&V: Childr. 2 yrs & over: 0,1 mg/kg up   Warnings and special precautions: Monit. pts. with signs of
   to max.4 mg by slow IVI. Rep. dos.in childr.who contin.to exp.N&V   GRANICIP, Cipla-Medpro [P/S]  sub-ac.intest.obstruct., pre-exist. dysrhythm., card.conduct.disords.&/
   not studied, theref.should not to be given.  Granisetron   pts.with concom. electrol.disturbs., concom.anti-dysrhythm. meds./
   Refer to prod.lit.for compat.with IV fluids/other meds.  Indications: Prev.of N&V assoc.with chemo-/radiother.  β-blocks./meds.prolong.QT-interv., hepat. impairm.
   Contraindications: Safety in pregn.not est., lactat., safety & effic.  (S4) TABS, 41/5.7.2/0397, 0398  Drug interactions: Total plasma clear.incr.with phenobarb.
   of post-op N&V treatm./ prophylax.in elderly not est., limit.data on   716740-001: 1 mg, 10, R394,93
   sev. ren./hepat.impairm., do not admin.in same syringe/infus.as other   715305-001: 2 mg, 5, R330,88  KYTRIL, Pharmaco [P/S]
   medicat., amps.not to be autoclav.  Dosage: Admin.1 hr bef.start.cytostat.-/radiother.  Granisetron
   Side effects: Hypersens.reacts.somet.sev. e.g. anaphylax., head-  Adults:  Indications: Prev.& treatm.ac.& delay.N&V assoc.with chemother.&
   ache, seiz., dizzin., movem. disords. incl.extrapyramid.reacts., vis.  Chemotherapeut.induc.N&V: Admin.1 mg 2xdly OR 2 mg once dly   radiother., post-op.N&V
   disturbs.incl. blindn., dysrhythm., bradycard., chest pain with/ with-  for up to 1 wk.follow.Ca ther. Limit.exper.beyond 7 chemother.cycles.  (S4) INJ, 31/5.7.2/0082, Y/5.7.2/272. 1 mg/ml
   out ST segm.depress., sensat.of warmth/ flush., hypotens., hiccups,   Radiother.induc.N&V: Admin.2 mg once dly.for up to 1 wk.fol-  861863-003: 5x1 ml amps, R273,32
   GI disords., liv.enzym. incr., loc.reacts.  low.radiother.  787019-003: 5x3 ml amps, R713,74
   Special precautions: Rout.post-op N&V prophylax. not recomm.  Contraindications: Childr.und.2 yrs., eval risk: benef.in pregn.&   Dosage: Chemother.induc.N & V: Adults: IVI: Prevent: Ad-
   where expectat.is slight, pass. into milk of lactat.rats, sod.restrict.diet,   lactat.as safety & effic.not est. & not known if excret.in breast milk.  min.1-3 mg (10-40 µg/kg) either as a slow IVI over 30 seconds or
   tot. dly.dos.of 8 mg not to be exceed.in mod./sev. hepat. impairm.,   Side effects: Poss.reduc.low. bowel motil., bld. dyscras., headache,   dil.with infus.sol.to a tot.vol.of 20-50 ml & admin.over 5 mins.prior.
   pts.exhibit.hypersens.reacts.to other select.5-HT3 recept.antagon.,   faint., agitat., dizzin., drowsin., insomn., dysrhythm., chest pain, con-  to chemother. Treatm: Admin.1-3 mg (10-40 µg/kg) either as a slow
   monit.subac. intest. obstruct.pts.  stip., abdom.pain, diarrh., dyspeps., unusual taste, anorex., rise in   IVI over 30 seconds or dil.with infus.sol.to a tot.vol.of 20-50 ml &
   Drug interactions: Decr.bld.conc.with phenytoin/ carbamazepine/   hepat.transaminas., alopec., unusual tiredn./weakn., allerg.reacts.  admin.over 5 mins. Admin.furth.reqd.dos.at least 10 mins.apart
   rifampicin, analges.eff.of tramadol poss.reduc.  incl anaphylax., skin rash, fev.  Max.dos.9 mg/24 hrs not to be exceed. IMI: Treatm.& prevent:
                                                              Admin.3 mg 15 mins.prior to chemother. Two subseq. 3 mg dos./24
   ASPEN GRANISETRON, (Aspen Pharmacare: Pharma)   Special precautions: Monit.pts.with signs of sub. ac.intest.ob-  hrs.if reqd. Paeds: IV admin.: Sngl. dos. of 10-40 µg/kg bm.( up to
   Pharmacare [P/S]             struct., do not admin.more than 9 mg(120 µg/kg)over 24 hrs., elderly,   3 mg) as IV infus.dil.in 10-30 ml over 5 mins. prior to chemother. One
                                ren.& hepat. impairm.
   Granisetron                                                addit.dos may be admin. within a 24 hr. period if req.but should be
   Indications: Prev.of N&V induc.by mod. emetogen. cytostat.ther.  Drug interactions: ¼ incr.in total plasma clear. of IV granisetron   at least 10 mins.apart from init.infus.
                                with phenobarbit.
   (S4) TABS, 42/5.7.2/1007, 1008                             Radiother.induc.N&V: IV: Adults: Prev: 1-3 mg (10-40 µg/kg) ei-
   713782-001: 1 mg, 10, R472,28  GRANISETRON FRESENIUS, Fresenius Kabi [P/S]  ther as a slow IVI over 30 seconds or dil.with infus.sol.to a tot.vol.of
   713784-001: 2 mg, 5, R385,28  Granisetron HCl              20-50 ml & admin. over 5 mins.prior.to radiother. Paeds: Insuffic.info.
   Dosage: Admin.1 hr bef.start.cytostat.ther.  Indications: Prev.& treatm.of N&V induc.by cytostat. ther., post-op.N&V.  Post-op.N&V: Adults: Prevent.& treatm: Admin. 1 mg (10 µg/kg)
   Admin. 1 mg 2xdly OR 2 mg once dly for up to 1 wk.follow.cyto-  (S4)CONC.FOR SOL.FOR INFUS/INJ, 44/5.7.2/0671, 0672. 1 mg/ml  as.slow.IVI (over 30 secs.) prior induc. anaesthes. Max.tot.dos.3 mg
   stat.ther.                   720942-001: 5x1 ml amps, R105,42  IV/day. Paeds.: Insuffic.info.
   Contraindications: Childr.und.2 yrs., pregn.& lactat.  720943-001: 5x3 ml amps, R316,27  (S4) TABS, 28/5.7.2/0162, 30/5.7.2/0346
   Side effects: Poss.reduc.low. bowel motil., headache, chest pain,   Dosage: Chemother.induc.N & V: Adults: IVI: Prevent: Ad-  812374-003: 1 mg, 10, R1 076,09
   hypotens., tachycard., bradycard., constip., hiccups, rise in hepat.   min.1-3 mg (10-40 µg/kg) either as a slow IVI over 30 secs or dil.with   701453-001: 2 mg, 5, R1 104,42
   transaminas., skin rash, anaphylax., somnol.  infus.sol.to a tot. vol.of 20-50 ml & admin.over 5 mins.prior.to chem-  Dosage: Chemother.induc.N&V: 1 mg 2xdly OR 2 mg once dly.
   Special precautions: Monit.pts.with signs of sub. ac.intest.ob-  other. Treatm: Admin.1-3 mg (10-40 µg/kg) either as a slow IVI over   for up to 1 wk.foll.chemother. Admin. 1st dos.1 hr.bef.ther. Do not
   struct., elderly, ren.& hepat. impairm., lact.intol.  30 secs or dil.with infus. sol. to a tot.vol.of 20-50 ml & admin.over 5   exceed max dos. 9 mg/24 hrs.
   Drug interactions: ¼ incr.in total plasma clear.of IV granisetron   mins. Admin.furth.reqd.dos.at least 10 mins.apart Max. dos.9 mg/24   Radiother.induc.N & V: Adults: 2 mg dly.up to 1 wk. foll.radiother.1   st
   with phenobarbit.            hrs not to be exceed. IMI: Prevent & treatm.: Admin.3 mg 15 mins.   dos.admin.within 1 hr.bef. ther.
   EMISTOP, Pharma Dynamics [P/S]  prior to chemother. Two subseq.3 mg dos./24 hrs.if reqd.  Contraindications: Childr.und.2 yrs., safety in pregn.& lactat.not est.
   Ondansetron hydrochlor.dihydrate  Childr.over 2yrs: IVI: Sngl.dos.of 10-40 µg/kg bm. (up to 3 mg) as IV   Side effects: Poss.reduc.low.bowel motil., headache, constip., skin
   Indications: Chemother.& radiother. induc.N&V, prev.& treatm.  infus.dil.in 10-30 ml over 5 mins. prior to chemother. One addit.dos   rash, allerg.react.& anaphylax., poss. rise in hepat.transaminas.
   of postop N&V.               may be admin. within a 24 hr.period if reqd.but should be at least   Special precautions: Monit.pts.with signs of sub. ac.intest.ob-
   (S4) SOL.FOR INJ, 2 mg/ml. A45/5.10/0386, 0387  10 mins.apart from init.infus. Insuffic.data avail for IMI admin.in childr.  struct., do not mix in sol.with other meds., complet.prophylact.admin.
   720786-001: 4 mg, 5 amps, R32,35  Radiother.induc.N&V: Adults: IVI prevent: 1-3 mg (10-40 µg/  bef.start. cytostat.ther./induc.anaesthes.
   720788-001: 8 mg, 5 amps, R74,10  kg) either as a slow IV inj. over 30 secs or dil.with infus.sol.to a tot.  Drug interactions: Incr.of ¼ in total plasma clear. of IV Kytril with
   Dosage: Emetogen.potent.of Ca treatm.varies accord. to dos. &   vol.of 20-50 ml & admin. over 5 mins.prior.to radiother. Childr.over   phenobarbit.
   combin.of chemo-/radiother. regim.used.   2 yrs: Insuffic.info.  MYLAN GRANISETRON, Mylan [P/S]
   Emetog.chemo-& radio ther.: Adults: 8 mg as slow IV/IM inj. in   Post-op.N&V: Adults: IVI prevent.& treatm: Admin. 1 mg (10 µg/  Granisetron
   not less than 30 sec.immed. bef.ther.foll.by 8 mg oral.12 hrly. Delay./   kg) as a slow.IV inj.over 30 secs. prior to anaesthes.induc.when for   Indications: Prev.& treatm.of N&V induc.by cytostat.ther.& post-
   prolong. emesis aft.24 hrs: Ondansetron may be contin. oral. Ad-  prev. Max. tot.dos.3 mg IV/day. Childr.over 2 yrs: Insuffic. info.  op.N&V
   min.8 mg 2x dly.for up to 5 days aft. treatm. course.  Contraindications: Childr.und.2 yrs., congenit. long QT syndr., safety   (S4) INJ, 41/5.7.2/0048. 3 mg/3 ml
   Highly emetogen.chemother: 8 mg as sngl.dos. by slow IV/IM inj.   in pregn.& lactat.not est.  714109-001: 5x3 ml amps, R504,59
   in not less than 30 sec.immed. bef.chemother. In pts.requir.high.dos.  Side effects: Poss.reduc.low.bowel motil., dysrhythm., ECG ab-  Dosage: Complet.prophylact.admin.bef.start. cytostat. ther./in-
   esp.those on high dos.cisplatin: 8 mg by slow IV/IM inj.immed. bef.  norm., hypersens.reacts.incl. anaphylax., oed., CNS effs., headache,   duc.anaesthes.
   chemother.foll.by 2 furth.IV/IM dos.of 8 mg 2-4 hrs apart/by const.  taste disord., dyston./dyskines.with 5-HT 3 antagon., abnorm. vis.,   Cytostat.ther: Adults: IV admin: 3 mg (40 µg/ kg) either as a slow
   infus.of 1 mg/hr for up to 24 hrs. OR sngl.16 mg dos.dil.in 50-100 ml   dizzin., hypo-/hypertens., GI disturbs., abnorm.hepat.funct., skin/  IVI over 30 seconds or dil.in infus. liq.to a tot.vol.of 20-50 ml & infus.
   saline or other compat.fluid infus.over not less than 15 mins.immed.  loc.reacts., fev., asthen.  over 5 mins. Up to 2 addit.3 mg dos.may be admin. Admin. addit.dos.
   bef.chemother. Sngl.dos.great. than 16 mg should not be giv. Ef-  Warnings and special precautions: Monit.pts. with signs of   at least 10 mins.apart. Max.dos. 9 mg(120 µg /kg)/24 hrs not to be
   fic.may be enhanc. by add.sngl.IV dos.of dexamethasone phosph.   subac.intest.obstruct., pre-exist. dysrhythm./ card.conduct.disords.,   exceed. Exper. beyond 7 chemother.cycles limit.
   20 mg 30-45 mins.prior to 1st Emistop dos.prior to chemother. De-  concom.anti-dysrhythm. agents./ β-blocks, do not mix in sol. with   Childr: IV admin: Prevent: Sngl.dos.of 10-40 µg/ kg bm.(up to 3 mg)
   lay./prolong.emesis aft.24 hrs: Contin. with oral 8 mg 2x dly.for up   other meds., elderly, ren.& hepat.impairm.  as IV infus.dil.in 10-30 ml over 5 mins. Treatm: Same as prevent.with
   to 5 days aft. treatm. course. Childr. over 4 yrs: 5 mg/m  IV over   Drug interactions: Incr.elimin.half-life with ketoconazole, incr.tot.  one addit. dos.of 10-40 µg/kg bm.(up to 3 mg) within 24 hr. period
                           2
   15 mins.immed.bef.chemother.follow.by oral ondansetron 4 mg   plasma clear.with phenobarb.  admin.at least 10 mins.apart from init. infus.
   12 hrly for up to 5 days.                                  Post-op.N&V: Adults: IV admin: Prevent: 1 mg by slow.IVI (over
   Prevent.& treatm.of post-op N&V: Adults: Immed. bef.anaesthes.  GRANTRYL, (Aspen Pharmacare: Pharma) Brimpharm [P/S]  30 secs.) prior induc.anaesthes. Treatm.of est.N&V: 1 mg by slow.
   induct./post-op: 4 mg undil. IM/IV in not less than 30 seconds,pref.  Granisetron  IVI (over 30 secs.). Max.tot.dos.3 mg IV/day in pts undergoing anaes-
   over 2-5 mins. OR admin.oral.1 hr bef.anaesthes.induct. Repeat.dos.  Indications: Prev.& treatm.of post-op N&V, N&V induc.by chem-  thes.for elect.surg. Childr: No data avail.
   for pts.contin.to exper.naus. &/vomit. post-op not studied. Childr.2 yrs   other./radiother.  Contra-indications: Childr.und.2 yrs., safety in pregn.& lactat.not est.
   & old: 0,1 mg/kg up to max.4 mg by slow IV inj.prior to/ at/aft. in-  (S4) INJ, 44/5.7.2/0892, 0893  Side-effects: Poss.reduc.low.bowel motil., headache, constipat.,
   duct. of anaesthes. Est. post-op N&V: 0,1 mg/kg up to max.4 mg by   721164-001: 1 mg/ml: 5 amps, R171,42  poss.rise in hepat. transaminas., allerg.react.incl.anaphylax., min.
   slow IV inj. Rep.dos.in childr. who contin.to exp.N&V not studied,   721165-001: 3 mg/3 ml, 5 amps, R514,27  skin rash., somnol.
   theref.should not to be giv.  Dosage: Chemother.induc.N&V: Adults: Prevent: 1-3 mg (10-  Special precautions: Monit.pts.with signs of sub.ac.intest.
   Refer to prod.lit.for compat.with IV fluids/other meds.  40 µg/ kg) admin.as slow IVI over 30 sec. or as IV infus.dilut.in 20-50 ml   obstruct., elderly, ren.& hepat. impairm., do not mix in sol.with
   Contraindications: Safety in pregn.not est., lactat., congen.long QT   infus. fluid admin.over 5 mins.bef.start.chemother. Treatm: Same as   other meds.,
   syndr., concom. apomorphine.  prevent. Furth.maint.dos.may be admin.at least 10 mins.apart if reqd.   Drug interactions: ¼ incr.in total plasma clear. with phenobarbit.
   Side effects: QT interv.prolong./torsade de point., sev.hypers-  Max.dos.per 24 hrs.not to exceed 9 mg. Childr: 10-40 µg/kg bm (up
   ens.reacts.incl.anaphylax., incr. large bowel trans.time, headache,   to 3 mg) admin.as IV infus.dilut.in 10-30 ml infus.fluid & admin.over   MYLAN ONDANSETRON, Mylan [P/S]
   seiz., dizzin., movem. disords. incl.oculogyr.cris./dyston.reacts./   5 mins.bef.start. chemother. One addit.dos.may be giv.with.a 24 hr per   Ondansetron as hydrochlor.dihydrate.
   dyskines., trans.vis.disturbs., dysrhythm., tachycard., bradycard.,   if requir. Addit.dos.not to be admin.until at least 10 mins.aft.init.infus.  Indications: Chemother.& radiother. induc. N&V, prevent.& treatm.
   chest pain with/-out ST segm. depress., flush., hypotens., hiccups,   Radiother.induc.N&V: Adults: Prevent: 1-3 mg (10-40 µg/ kg)   of post-op N&V.
   skin./ loc.reacts.           admin.as slow IVI over 30 sec. or as IV infus.dilut.in 20-50 ml infus.  (S4) INJ, A39/5.10/0509, 0510. 2 mg/ml.
   Warnings and special precautions: Rout. prophylax.not recomm.  fluid admin.over 5 mins.bef.start.radiother. Childr: Not recomm.  705537-001: 5x2 ml amps, R36,83.
   where expect.of N&V small, pass.into milk of lactat.animals, tot.dly.  due to lack of data.  705538-001: 5x4 ml amps, R84,36.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page120.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page116.html">116</a>&nbsp;&nbsp;&nbsp;<a href="page117.html">117</a>&nbsp;&nbsp;&nbsp;<a href="page118.html">118</a>&nbsp;&nbsp;&nbsp;<a href="page119.html">119</a>&nbsp;&nbsp;&nbsp;<a href="page120.html">120</a>&nbsp;&nbsp;&nbsp;<a href="page121.html">121</a>&nbsp;&nbsp;&nbsp;<a href="page122.html">122</a>&nbsp;&nbsp;&nbsp;<a href="page123.html">123</a>&nbsp;&nbsp;&nbsp;<a href="page124.html">124</a>&nbsp;&nbsp;&nbsp;<a href="page125.html">125</a>&nbsp;&nbsp;&nbsp;<a href="page126.html">126</a>
             </td>
             <td width="35%"><a href="page122.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page122.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
